TrialJournal of comparative effectiveness research2024

Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons.

Tammy Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.